New data from a National Institutes of Health-funded study reveals that midlife brings substantial remodeling to the immune cell landscape of the human hippocampus, pointing to a potential mechanism behind chronic neuroinflammation in neurodegenerative diseases. Scientists analyzed postmortem hippocampal tissue from 40 neurologically healthy adults aged 20 to 95 years old, as detailed in a … Read more
Researchers at the Keck School of Medicine of USC have identified a 3D hierarchy of DNA “enhancers” that function as master switches for prostate cancer development. According to a study published in Genome Biology, these interconnected networks control gene expression, revealing potential new targets for precision cancer therapies that could move beyond current gene-specific treatments. … Read more
Epigenetic clocks—tools designed to measure biological age through DNA methylation—capture distinct, non-overlapping biological processes rather than a single universal aging mechanism. According to a study published in npj Aging, researchers have developed Transcriptomic Aging Gene Scores (TAGS) to better interpret these clocks, showing that gene expression patterns often predict health outcomes like mortality and frailty … Read more
Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer death, with patient outcomes hindered by late diagnosis and scarce early biomarkers. According to a 2026 review in the journal Gene Expression, advancements in multi-omics and liquid biopsy are shifting the clinical landscape by enabling more precise prognostic tracking and personalized immunotherapy selection, though … Read more
Acute myeloid leukemia (AML), a fast-growing cancer with a 29% survival rate, is being redefined by a breakthrough in epigenomic mapping. A study published in Nature by researchers at Kyoto University and the Karolinska Institute identified 16 distinct epigenomic subgroups of AML based on chromatin accessibility. This research demonstrates that chromatin architecture, rather than gene … Read more
Researchers from the Sant Pau Research Institute (IR Sant Pau) and CIBERER have developed an AI tool that identifies hundreds of molecular signals to predict venous thrombosis. By integrating clinical, genetic, and transcriptomic data, the system improves risk stratification for idiopathic venous thromboembolism, as detailed in the Journal of Thrombosis and Haemostasis. Why do some … Read more
Researchers have identified 63 high-confidence activators of poly(A) site usage, a critical process in gene expression. Led by Gene Yeo of UC San Diego and Yongsheng Shi of UC Irvine, the study, published June 26, 2026, in Molecular Cell, provides a new programmable framework for manipulating RNA processing in human cells. How do these newly … Read more
Researchers have identified the ILF2 protein as a critical regulator of diabetic wound healing, acting as a molecular brake that prevents the cellular senescence responsible for chronic diabetic foot ulcers (DFU). According to a study published March 17, 2026, in the journal Burns & Trauma, the loss of ILF2 leads to the accumulation of NPM1 … Read more
Long-standing psychological traits, including neuroticism and a lack of purpose, track distinct molecular pathways in Alzheimer’s dementia, according to a multi-omics study published in Translational Psychiatry. Researchers from the Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP) found that while traditional pathology and genetic risk factors identify overall disease susceptibility, these … Read more
Rethinking Cancer Treatment: Why Traditional Drug Mechanisms Are Being Challenged For decades, the oncology community has operated under a relatively stable blueprint regarding how certain cancer drugs function. One of the most prominent examples involves histone deacetylase (HDAC) inhibitors—a class of drugs designed to alter how genes are turned on and off to combat tumor … Read more